Dr Naila Rabbani
Professor of Basic Medical Science, College of Medicine, QU Health, Qatar University, Doha, Qatar
Dr Naila Rabbani is the head of proteomics at QU Health at Qatar University. She is a leading glycation researcher, developed the AGEomics technology and an expert in the development of diagnostic algorithms. She is pursuing research on glyoxalase 1 inducers for prevention, reversal and treatment of type 2 diabetes and chronic vascular complications of diabetes and biomarkers for risk prediction of diabetic vascular complications, arthritis and autism. Recently, she is also studying application of glyoxalase research in the treatment of COVID19. She has over 144 publications and 9 patents, receiving over 14,000 citations and h-index 63 and is ranked in the top 4% scientists globally for citation of her work.
